56.30
-0.20
(-0.35%)
At close: 2:59:23 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-37,537.00
-37,537.00
52,240.00
15,326.00
74,900.00
Investing Cash Flow
-4,518.00
-4,518.00
-8,093.00
-19,607.00
-25,546.00
Financing Cash Flow
456,300.00
456,300.00
-12,436.00
28,238.00
-44,374.00
End Cash Position
504,131.00
504,131.00
89,845.00
58,255.00
34,266.00
Capital Expenditure
-4,911.00
-4,911.00
-5,289.00
-7,714.00
-21,680.00
Issuance of Capital Stock
500,000.00
500,000.00
--
13,092.00
--
Issuance of Debt
30,000.00
30,000.00
--
44,000.00
--
Repayment of Debt
-69,137.00
-69,137.00
-9,694.00
-9,775.00
-24,241.00
Free Cash Flow
-42,448.00
-42,448.00
46,951.00
7,612.00
53,220.00
12/31/2020 - 6/20/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4170.TWO VBI
14.10
+0.71%
7754.TWO AnnJi
32.55
-3.70%
4197.TWO Visgeneer Inc.
9.78
0.00%
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
6748.TWO ACRO Biomedical Co., Ltd.
24.80
+1.02%
6827.TWO MegaPro Biomedical Co., Ltd
14.45
+2.48%
6580.TWO TaiRx, Inc.
26.00
+1.96%
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.98
-2.80%
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
18.90
+2.16%